BioSpace News Archive

Harvard Bioscience, Inc. announced financial results for the period ended December 31, 2021.

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes announced it will be presenting clinical data at the upcoming SAGES 2022 Annual Meeting, being held on March 16-19, 2022 in Denver, Colorado.

Calyxt, Inc., a plant-based synthetic biology company, announced that management will participate in a fireside chat at the 34th Annual Roth Conference at the Ritz-Carlton in Dana Point, CA.

Travere Therapeutics, Inc. announced its intention to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible senior notes due 2029 in an underwritten offering.

Creyon Bio, Inc., a drug development company engineering RNA-based medicines and their components with predictable safety and efficacy profiles, launched with the goal of making precision medicines on demand a real possibility for populations ranging from one patient to millions.

ANANDA Scientific Inc . today announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S , an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology.

Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in a fireside chat at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 8:00 a.m. ET.

VUZE Medical has received additional patents for its VUZE™ System in the U.S., Europe and China.

Taysha Gene Therapies, Inc. announced its participation in two fireside chats at the Oppenheimer 32nd Annual Virtual Healthcare Conference on Monday, March 14, 2022, and Tuesday, March 15, 2022.

Pluristem Therapeutics Inc. and Tnuva Group jointly announced the appointment of Eyal Rosenthal as Chief Executive Officer of their landmark joint venture to develop, manufacture and commercialize cultured meat.